[1-(aminomethyl)-2-oxabicyclo[2.1.1]hexan-4-yl]methanol, 98%, 500mg

[(3S,4S)-4-methoxy-1,1-dioxidotetrahydro-3-thienyl]amine hydrochloride, 95.0%, 250mg

1-(2-hydroxyethyl)-6-mercapto-1,5-dihydro-4{H}-pyrazolo[3,4-{d}]pyrimidin-4-one, 95.0%, 500mg

3-AMINO-5-FLUOROPYRIDINE-2-CARBONITRILE, 95.0%, 50mg

N-FMOC-L-ASPARTIC ACID 1-(9-FLUORENYLMETHYL) ESTER, 95%, 5g

1-(4-Chloro-2-nitrophenyl)ethanone, 95.0%, 25g

(2,3-Difluorophenyl)(4-methylpiperazin-1-yl)methanone, 98%, 1g

3-Hydroxy-2-methoxybenzaldehyde, 95.0%, 250mg

5-(4-chloro-2-fluorophenyl)-2-furaldehyde, 95.0%, 1g

3,5-Bis(tert-butylthio)benzyl Acetate>98.0%(GC)1g

Methyl 1H-1,2,4-triazole-3-carboxylate, 88.0%, 500g

Cinchonidine>98.0%(T)25g

DL-Cystin, min. 98,5 %, 1 g, Glasverpackung